Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Which patients with a parapneumonic effusion need a chest tube?

Scott A. Helgeson, MD, Brett T. Hiroto, MD, Scott J. Billings, MD, Courtney L. Scott, DO and Michele D. Lewis, MD
Cleveland Clinic Journal of Medicine August 2018, 85 (8) 609-611; DOI: https://doi.org/10.3949/ccjm.85a.17036
Scott A. Helgeson
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brett T. Hiroto
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott J. Billings
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Courtney L. Scott
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele D. Lewis
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Hospitalized patients with pneumonia who develop a complicated parapneumonic effusion or empyema need to undergo chest tube placement.

WHAT IS PARAPNEUMONIC EFFUSION?

Parapneumonic effusion is a pleural effusion that forms concurrently with bacterial or viral pneumonia. Up to 40% of patients hospitalized with pneumonia develop a parapneumonic effusion.1 The effusion progresses through a continuum of 3 stages: uncomplicated, complicated, and empyema.

Uncomplicated parapneumonic effusion is an exudative effusion without bacteria or pus that is caused by movement of fluid and neutrophils into the pleural space. Pneumonia itself causes an increase in interstitial fluid and capillary leakage. The effusion becomes complicated as a result of bacteria invading the pleural space, causing a further increase in neutrophils in the pleural fluid. Empyema is defined as the presence of frank pus in the pleural space.

CLINICAL SIGNIFICANCE

According to the US Centers for Disease Control and Prevention, pneumonia accounts for 674,000 emergency department visits each year; of the patients hospitalized, up to 40% develop a parapneumonic effusion.2 The only study done on rates of death associated with parapneumonic effusion showed that, compared with patients with no effusion, the risk of death was 3.7 times higher with a unilateral effusion and 6.5 times higher with bilateral effusions.3

INITIAL EVALUATION

The initial evaluation of suspected parapneumonic effusion should include chest radiography with lateral or decubitus views, followed by thoracentesis if indicated. If thoracentesis is performed, the fluid should be tested as follows:

  • Gram stain

  • Appropriate cultures based on clinical scenario (eg, aerobic, anaerobic, fungal)

  • Total protein in pleural fluid and serum

  • Lactate dehydrogenase (LDH) in pleural fluid and serum

  • Glucose

  • pH.

CLASSIFICATION OF EFFUSIONS

When pleural fluid is obtained, the total protein and LDH levels are used to categorize the effusion as either transudative or exudative based on the Light criteria.4 An effusion is confirmed as exudative when 1 of the following 3 criteria is met:

  • The ratio of pleural fluid protein to serum protein is greater than 0.5

  • The ratio of pleural fluid LDH to serum LDH is greater than 0.6

  • The pleural fluid LDH is greater than two-thirds the upper limit of normal for the serum LDH.

Once an effusion is characterized as exudative, the American College of Chest Physicians consensus guidelines are used for further classification and prognostication.5 The guidelines estimate the risk of poor outcome by dividing the effusions based on their characteristics: the anatomy of the effusion, the bacteriology of the fluid, and the chemistry of the pleural fluid (Table 1). Based on these guidelines, effusions are divided into 4 categories. Category 1 and 2 effusions are considered uncomplicated, category 3 is considered complicated, and category 4 is empyema. The outcomes of interest are prolonged hospitalization, prolonged systemic toxicity, increased ventilator impairment, increased morbidity rate, and increased mortality rate.5

View this table:
  • View inline
  • View popup
TABLE 1

Parapneumonic effusion: Categories, management, and prognosis

Category 1 effusions are defined as free-flowing fluid with a thickness of less than 10 mm on any imaging modality. Thoracentesis for pleural fluid analysis is not required. The prognosis is very good.

Category 2 effusions are defined as free-flowing fluid with a thickness greater than 10 mm and less than 50% of the hemithorax. Thoracentesis is typically done because of the size of the effusion, but Gram stain and culture of the pleural fluid are usually negative, and the pH is at least 7.2. The prognosis is good.

Category 3 effusions are considered complicated because the anatomy of the pleural space becomes altered or because bacteria have invaded the pleural space. The effusion is larger than 50% of the hemithorax or is loculated, or the parietal pleura is thickened. Since the bacteria have invaded the pleural space, Gram stain or culture of pleural fluid may be positive, the pleural fluid pH may be less than 7.2, or the glucose level of the fluid may be less than 60 mg/dL. The prognosis for category 3 is poor.

Category 4 effusions are defined as empyema. The only characteristic that separates this from category 3 is frank pus in the pleural space. The prognosis is very poor.

TO PLACE A CHEST TUBE OR NOT

For category 1 or 2 effusions, treatment with antibiotics alone is typically enough. Category 3 effusions usually do not respond to antibiotics alone and may require complete drainage of the fluid with or without a chest tube depending on whether loculations are present, as loculations are difficult to drain with a chest tube. Category 4 effusions require both antibiotics and chest tube placement.

WHAT TYPE OF CHEST TUBE?

Studies have shown that small-bore chest tubes (< 20 F) are as efficacious as larger tubes (≥ 20 F) for the treatment of complicated parapneumonic effusion and empyema.6,7 Studies have also shown that the size of the tube makes no difference in the time needed to drain the effusion, the length of hospital stay, or the complication rate.8,9 Based on these studies, a small-bore chest tube should be placed first when clinically appropriate. When a chest tube is placed for empyema, computed tomography should be performed within 24 hours to confirm proper tube placement.

ADVANCED THERAPIES FOR EMPYEMA

Empyema treatment fails when antibiotic coverage is inadequate or when a loculation is not drained appropriately. Options if treatment fails include instillation of fibrinolytics into the pleural space, video-assisted thorascopic surgery, and decortication.

The role of fibrinolytics has not been well-established, but fibrinolytics should be considered in loculated effusions or empyema, or if drainage of the effusion slows.10 Video-assisted thorascopic surgery is reserved for effusions that are incompletely drained with a chest tube with or without fibrinolytics; studies have shown shorter hospital length of stay and higher treatment efficacy when this is performed earlier for loculated effusions.11 Decortication is reserved for symptomatic patients who have a thickened pleura more than 6 months after the initial infection.12 Timing for each of these procedures is not clearly defined and so must be individualized.

TAKE-AWAY POINTS

  • Parapneumonic effusion occurs concurrently with pneumonia and with a high frequency.1

  • Effusions are associated with an increased risk of death.3

  • Categorizing the effusion helps guide treatment.

  • Chest tubes should be placed for some cases of complicated effusion and for all cases of empyema.

  • A small-bore chest tube (< 20 F) should be tried first.

  • Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Light RW
    . Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006; 3(1):75–80. doi:10.1513/pats.200510-113JH
    OpenUrlCrossRefPubMed
  2. ↵
    1. US Department of Health and Human Services
    2. Centers for Disease Control and Prevention
    3. National Center for Health Statistics
    . National hospital ambulatory medical care survey: 2013 emergency department summary tables. www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2013_ed_web_tables.pdf.
  3. ↵
    1. Hasley PB,
    2. Albaum MN,
    3. Li YH,
    4. et al
    . Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med 1996; 156(19):2206–2212. doi:10.1001/archinte.1996.00440180068008
    OpenUrlCrossRefPubMed
  4. ↵
    1. Light RW,
    2. Macgregor MI,
    3. Luchsinger PC,
    4. Ball WC
    . Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77(4):507–513. doi:10.7326/0003-4819-77-4-507
    OpenUrlCrossRefPubMed
  5. ↵
    1. Colice GL,
    2. Curtis A,
    3. Deslauriers J,
    4. et al
    . Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118(4):1158–1171. doi:10.1378/CHEST.118.4.1158
    OpenUrlCrossRefPubMed
  6. ↵
    1. Ali I,
    2. Unruh H
    . Management of empyema thoracis. Ann Thorac Surg 1990; 50(3):355–359. doi: https://doi.org/10.1016/0003-4975(90)90474-K
    OpenUrlCrossRefPubMed
  7. ↵
    1. Ashbaugh DG
    . Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991; 99(5):1162–1165. doi:10.1378/CHEST.99.5.1162
    OpenUrlCrossRefPubMed
  8. ↵
    1. Cooke DT,
    2. David EA
    . Large-bore and small-bore chest tubes: types, function, and placement. Thorac Surg Clin 2013; 23(1):17–24. doi:10.1016/j.thorsurg.2012.10.006
    OpenUrlCrossRefPubMed
  9. ↵
    1. Halifax RJ,
    2. Psallidas I,
    3. Rahman NM
    . Chest drain size: the debate continues. Curr Pulmonol Rep 2017; 6(1):26–29. doi:10.1007/s13665-017-0162-3
    OpenUrlCrossRef
  10. ↵
    1. Maskell NA,
    2. Davies CW,
    3. Nunn AJ,
    4. et al
    5. First Multicenter Intrapleural Sepsis Trial (MIST1) Group
    . UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352(9):865–874. doi:10.1056/NEJMoa042473
    OpenUrlCrossRefPubMed
  11. ↵
    1. Wait MA,
    2. Sharma S,
    3. Hohn J,
    4. Dal Nogare A
    . A randomized trial of empyema therapy. Chest 1997; 111(6):1548–1551. doi:10.1378/chest.111.6.1548
    OpenUrlCrossRefPubMed
  12. ↵
    1. Rzyman W,
    2. Skokowski J,
    3. Romanowicz G,
    4. Lass P,
    5. Dziadziuszko R
    . Decortication in chronic pleural empyema—effect on lung function. Eur J Cardiothorac Surg 2002; 21(3):502–507. doi: https://doi.org/10.1016/S1010-7940(01)01167-8
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (8)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 8
1 Aug 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Which patients with a parapneumonic effusion need a chest tube?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Which patients with a parapneumonic effusion need a chest tube?
Scott A. Helgeson, Brett T. Hiroto, Scott J. Billings, Courtney L. Scott, Michele D. Lewis
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 609-611; DOI: 10.3949/ccjm.85a.17036

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Which patients with a parapneumonic effusion need a chest tube?
Scott A. Helgeson, Brett T. Hiroto, Scott J. Billings, Courtney L. Scott, Michele D. Lewis
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 609-611; DOI: 10.3949/ccjm.85a.17036
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • WHAT IS PARAPNEUMONIC EFFUSION?
    • CLINICAL SIGNIFICANCE
    • INITIAL EVALUATION
    • CLASSIFICATION OF EFFUSIONS
    • TO PLACE A CHEST TUBE OR NOT
    • WHAT TYPE OF CHEST TUBE?
    • ADVANCED THERAPIES FOR EMPYEMA
    • TAKE-AWAY POINTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Critical Care
  • Hospital Medicine
  • Pulmonology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire